Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2010 | 1 |
2011 | 2 |
2012 | 1 |
2014 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Loss of pro-apoptotic Bax and Bak increases resistance to dihydroartemisinin-mediated cytotoxicity in normoxia but not in hypoxia in HCT116 colorectal cancer cells.
Free Radic Biol Med. 2021 Oct;174:157-170. doi: 10.1016/j.freeradbiomed.2021.08.012. Epub 2021 Aug 14.
Free Radic Biol Med. 2021.
PMID: 34403740
Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells.
Ontikatze T, Rudner J, Handrick R, Belka C, Jendrossek V.
Ontikatze T, et al.
Front Oncol. 2014 May 19;4:116. doi: 10.3389/fonc.2014.00116. eCollection 2014.
Front Oncol. 2014.
PMID: 24904829
Free PMC article.
Item in Clipboard
Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway.
Handrick R, Ontikatze T, Bauer KD, Freier F, Rübel A, Dürig J, Belka C, Jendrossek V.
Handrick R, et al. Among authors: ontikatze t.
Mol Cancer Ther. 2010 Sep;9(9):2497-510. doi: 10.1158/1535-7163.MCT-10-0051. Epub 2010 Jul 27.
Mol Cancer Ther. 2010.
PMID: 20663933
Item in Clipboard
PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia.
Xenaki G, Ontikatze T, Rajendran R, Stratford IJ, Dive C, Krstic-Demonacos M, Demonacos C.
Xenaki G, et al. Among authors: ontikatze t.
Oncogene. 2008 Oct 2;27(44):5785-96. doi: 10.1038/onc.2008.192. Epub 2008 Jun 23.
Oncogene. 2008.
PMID: 18574470
Free PMC article.
Item in Clipboard
Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.
Lietz R, Bayer W, Ontikatze T, Johrden L, Tenbusch M, Storcksdieck Genannt Bonsmann M, Uberla K, Dittmer U, Wildner O.
Lietz R, et al. Among authors: ontikatze t.
J Virol. 2012 Feb;86(3):1706-16. doi: 10.1128/JVI.06244-11. Epub 2011 Nov 16.
J Virol. 2012.
PMID: 22090142
Free PMC article.
Item in Clipboard
Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.
Bayer W, Lietz R, Ontikatze T, Johrden L, Tenbusch M, Nabi G, Schimmer S, Groitl P, Wolf H, Berry CM, Uberla K, Dittmer U, Wildner O.
Bayer W, et al. Among authors: ontikatze t.
Retrovirology. 2011 Sep 26;8:75. doi: 10.1186/1742-4690-8-75.
Retrovirology. 2011.
PMID: 21943056
Free PMC article.
Item in Clipboard
Cite
Cite